| Ajanta Pharma Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 532331 |
NSE Symbol : AJANTPHARM |
P/E(TTM) : 34.69 |
|
ISIN Demat : INE031B01049 |
Div & Yield% : 1.06 |
EPS(TTM) : 76.07 |
|
Book Value(₹) : 330.39 |
Market Cap(₹Cr) : 32,967.39 |
Face Value(₹) : 2.00 |
| Particulars | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 1,220.24 | 1,208.56 | 1,013.94 | 1,101.92 | 1,128.91 | 1,077.27 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 1,220.24 | 1,208.56 | 1,013.94 | 1,101.92 | 1,128.91 | 1,077.27 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 75.03 | 40.63 | 17.93 | 33.23 | 40.34 | 28.37 |
| Total Income | 1,295.27 | 1,249.19 | 1,031.87 | 1,135.15 | 1,169.25 | 1,105.64 |
| Total Expenditure | 930.65 | 879.16 | 764.29 | 765.59 | 826.00 | 761.44 |
| PBIDT | 364.62 | 370.03 | 267.58 | 369.56 | 343.25 | 344.20 |
| Interest | 0.73 | 0.73 | 0.67 | 2.48 | 0.73 | 0.72 |
| PBDT | 363.89 | 369.30 | 266.91 | 367.08 | 342.52 | 343.48 |
| Depreciation | 41.92 | 40.31 | 38.76 | 34.93 | 33.32 | 32.92 |
| Tax | 65.97 | 70.73 | 39.10 | 76.38 | 71.13 | 71.42 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 6.47 | 3.29 | -4.38 | 3.32 | 3.09 | 3.11 |
| Reported Profit After Tax | 249.53 | 254.97 | 193.43 | 252.45 | 234.98 | 236.03 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 249.53 | 254.97 | 193.43 | 252.45 | 234.98 | 236.03 |
| EPS (Unit Curr.) | 19.98 | 20.41 | 15.46 | 20.16 | 18.75 | 18.77 |
| EPS (Adj) (Unit Curr.) | 19.98 | 20.41 | 15.46 | 20.16 | 18.75 | 18.77 |
| Calculated EPS (Unit Curr.) | 19.91 | 20.34 | 15.43 | 20.14 | 18.75 | 18.83 |
| Calculated EPS (Adj) (Unit Curr.) | 19.91 | 20.34 | 15.43 | 20.14 | 18.75 | 18.83 |
| Calculated EPS (Ann.) (Unit Curr.) | 79.63 | 81.36 | 61.72 | 80.56 | 74.98 | 75.32 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 79.63 | 81.36 | 61.72 | 80.56 | 74.98 | 75.32 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 1,400.00 | 0.00 |
| Equity | 25.07 | 25.07 | 25.07 | 25.07 | 25.07 | 25.07 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 29.88 | 30.62 | 26.39 | 33.54 | 30.41 | 31.95 |
| PBDTM(%) | 29.82 | 30.56 | 26.32 | 33.31 | 30.34 | 31.88 |
| PATM(%) | 20.45 | 21.10 | 19.08 | 22.91 | 20.81 | 21.91 |